oncology split

As per yearoftheeel's post "Pete and Charles are both in the US", strengthens my thought that we will definitely have a nasdaq listing. It makes sense, bigger market, more money and investors to get on board.

Pete has said that current share holders will own the same amount of oncology and fonda companies, as they do at the moment - so if you own 1% of ACL, you will own 1% of both companies after the split (obviously before any capital raising.

Here's my thoughts......

RBS have a target price for ACL at .89c with oncology worth .29c. So if oncology company floated with the same amount of shares (280M) then the market cap would be at $81 mill, which to me sounds about right.

I can't see that we would float on the nasdaq with this many shares and at a price this low - and it has also been mentioned that we would recieve a pro rata amount in line with our current holding........so with that in mind, this is the formula I have come up with for the new oncology company.

Floating 28 Million shares which give us a pro rata amount of one oncology share to every 10 ACL shares (which are valued at .29c), there for every share in oncology is worth $2.90. So for every 100,000 acl shares you currently have, you recieve 10,000 shares in oncology valued at $29,000 giving us a market cap of $81 Million.

Then we would need a capital raising and it has been suggested that it should be in the order of $50 Mill, so that would mean just over 17 million new shares (at $2.90), giving a total of roughly 45 million shares on offer and a market cap over $130 Million.

So if we become this illusive $1 billion dollar company, my calculations put a share value at $22 per share giving our initial 10,000 shares a new value of $220,000.

Happy to discuss my ideas, I hope the calculations add up, I was in a hurry putting this out and it all made sense while I was eating my porridge this morning.

Enjoy the ride